(5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol

C34H37N9O4 — CID 90325116

IUPAC(5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol
SMILESCc1nc(-c2cccc(-c3nc(C4=N[C@H](O)ON4)nc4nc(N5CCOC[C@H]5c5ccccc5)n(CC5CCC(C)CC5)c34)c2)no1
InChIInChI=1S/C34H37N9O4/c1-20-11-13-22(14-12-20)18-43-28-27(24-9-6-10-25(17-24)29-35-21(2)46-40-29)36-31(32-39-34(44)47-41-32)37-30(28)38-33(43)42-15-16-45-19-26(42)23-7-4-3-5-8-23/h3-10,17,20,22,26,34,44H,11-16,18-19H2,1-2H3,(H,39,41)/t20?,22?,26-,34+/m0/s1
InChIKeyWJIGMVCROZDYRE-WYYCFIGVSA-N
MW635.73 g/mol
LogP4.81
Rot. Bonds7

About (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol

(5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol (PubChem CID 90325116) has the molecular formula C34H37N9O4 and a molecular weight of 635.73 g/mol. Its IUPAC name is (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol.

Molecular Properties

Compound Name(5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol
PubChem CID90325116
Molecular FormulaC34H37N9O4
Molecular Weight635.73 g/mol
Exact Mass635.30
IUPAC Name(5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol
SMILESCc1nc(-c2cccc(-c3nc(C4=N[C@H](O)ON4)nc4nc(N5CCOC[C@H]5c5ccccc5)n(CC5CCC(C)CC5)c34)c2)no1
InChIInChI=1S/C34H37N9O4/c1-20-11-13-22(14-12-20)18-43-28-27(24-9-6-10-25(17-24)29-35-21(2)46-40-29)36-31(32-39-34(44)47-41-32)37-30(28)38-33(43)42-15-16-45-19-26(42)23-7-4-3-5-8-23/h3-10,17,20,22,26,34,44H,11-16,18-19H2,1-2H3,(H,39,41)/t20?,22?,26-,34+/m0/s1
InChIKeyWJIGMVCROZDYRE-WYYCFIGVSA-N
XLogP4.81
TPSA148.84 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms47
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500635.73
LogP ≤ 54.81
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
The IUPAC name of (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol (CID 90325116) is (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol.
What is the SMILES notation for (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
The canonical SMILES for (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol is Cc1nc(-c2cccc(-c3nc(C4=N[C@H](O)ON4)nc4nc(N5CCOC[C@H]5c5ccccc5)n(CC5CCC(C)CC5)c34)c2)no1.
What is the InChIKey of (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
The InChIKey is WJIGMVCROZDYRE-WYYCFIGVSA-N. The full InChI is InChI=1S/C34H37N9O4/c1-20-11-13-22(14-12-20)18-43-28-27(24-9-6-10-25(17-24)29-35-21(2)46-40-29)36-31(32-39-34(44)47-41-32)37-30(28)38-33(43)42-15-16-45-19-26(42)23-7-4-3-5-8-23/h3-10,17,20,22,26,34,44H,11-16,18-19H2,1-2H3,(H,39,41)/t20?,22?,26-,34+/m0/s1.
What are the key properties of (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
(5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol has a molecular weight of 635.73 g/mol, XLogP of 4.81, 7 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-3-[7-[(4-methylcyclohexyl)methyl]-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-[(3R)-3-phenylmorpholin-4-yl]purin-2-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol is sourced from PubChem (CID 90325116), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).